This Life Sciences Supplier Plunges 50% as Fund Buys Stock
A leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...
We compare Which Dividend Aristocrats Etf Did Best In 2024, spotlighting performance leaders and factors behind stronger returns.
23,392 articlesA leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...
The WNBA and the players union announced an agreement in principle on a new collective bargaining agreement, promisin...
bitcoin’s price slips below $70,000 as markets wobble amid geopolitical headlines. Playnance's GCOIN is aiming for a ...
Planet Labs reports a record Q4 revenue and a backlog eclipsing annual sales, spurring a sharp after hours rally as i...
A deadly LaGuardia collision puts the spotlight on air-traffic control fatigue, staffing gaps, and how these issues r...
Two big reasons explain why the fear around IBM's COBOL future might be overstated. This piece breaks down why COBOL ...
HomeServices of America unveils Maestro, an AI-backed operating system for its real estate agents, consolidating sear...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
SoundHound AI's 2026 earnings journey sheds light on how voice AI monetizes across devices. This guide breaks down th...
Oklo stock climbing higher this week is driven by regulatory progress on its Aurora reactor and broader interest in a...
The AI race keeps evolving, and Alphabet sits at the center. A rumored Anthropic cloud deal hints at how hyperscale i...
Bank of America raises NVIDIA's price target to $320, backing the move with a brighter view of a $1.7 trillion AI dat...